Non-synaptic transmission is pervasive throughout the nervous system. It appears especially prevalent in peripheral ganglia, where non-synaptic interactions between neighboring cell bodies have been described in both physiological and pathological conditions, a phenomenon referred to as cross-depolarization (CD) and thought to play a role in sensory processing and chronic pain. CD has been proposed to be mediated by a chemical agent, but its identity has remained elusive. Here, we report that in the rat dorsal root ganglion (DRG), the P2Y1 purinergic receptor (P2RY1) plays an important role in regulating CD. The effect of P2RY1 is cell-type specific: pharmacological blockade of P2RY1 inhibited CD in A-type neurons while enhancing it in unmyelinated C-type cells.
Introduction
Although research on neuroscience predominantly focuses on the synaptic modality of information transfer, non-synaptic transmission also represents an important and extremely prevalent phenomenon in the nervous system of mammals, including humans-for example, many of the major neurotransmitters can act non-synaptically (Herkenham 1987 , Descarries, Gisiger et al. 1997 , Descarries and Mechawar 2000 , Vizi, Fekete et al. 2010 , Ren, Qin et al. 2011 . As opposed to synapses, where diffusion of the neurotransmitter is generally confined to a narrow intercellular gap, in nonsynaptic communication the signaling agent diffuses, relatively unrestrained, in the extracellular space, potentially reaching distant targets (Agnati, Zoli et al. 1995, Carvalho and Damasio 2019) . Non-synaptic communication appears particularly prominent in peripheral sensory ganglia (Amir and Devor 1996 , Oh and Weinreich 2002 , Kim, Anderson et al. 2016 , Du, Hao et al. 2017 . For example, in dorsal root ganglia (DRG), where synapses are exceedingly rare (Lieberman 1976) , most neurons can be depolarized following repetitive activation of neighboring cells (Amir and Devor 1996) . This phenomenon, known as cross-depolarization (CD), is predominantly excitatory (Amir and Devor 1996) and can be exacerbated upon injury, but is present in healthy neurons in physiological conditions (Devor and Wall 1990, Amir and Devor 1996) . CD has also been described in the nodose ganglion of the vagus (Oh and Weinreich 2002) and may therefore represent a general physiological property of intraganglionic neuronal communication. Despite its prevalence and probable physiological relevance, the exact function of the intraganglionic non-synaptic crosstalk remains mysterious and its mechanisms remain elusive. They may involve the release of diffusible neurochemical substances (Amir and Devor 1996) , but this scenario remains unconfirmed and the identity of the molecule(s) involved has not been elucidated.
Our results implicate the P2Y1 purinergic receptor (P2RY1) in non-synaptic CD of DRG neurons. Strikingly, our findings indicate that P2RY1 operates with cell-type specificity. P2RY1 blockade inhibits CD in myelinated A-type neurons, but enhances it in unmyelinated C-cells. We also report that CD mechanisms may not be conserved across peripheral ganglia. Eliminating extracellular calcium had no significant effect on CD magnitude in the DRG, whereas it is essential in a large number of nodose ganglion neurons (Oh and Weinreich 2002) . Finally, we report a role for DRG glia in CD. Glial function blockade selectively enhanced CD in C-type neurons. Our results constitute the first description of a neurochemical mechanism for CD in sensory ganglia and suggest possible physiological roles of this widespread phenomenon.
Materials and Methods

Tissue preparation
Male Sprague-Dawley rats weighing 300-350 g were anesthetized with isoflurane and oxygen (5:2 for induction, 3:1 for maintenance). Tissues were exposed in layers and L5 DRG were dissected bilaterally together with their respective spinal nerves and dorsal roots and cleaned of surrounding connective tissue. The preparations were allowed to recover for ~2 hrs at room temperature in Ca 2+ -free artificial cerebrospinal fluid (ACSF, 124 mM NaCl, 3.5 mM KCl, 1.25 mM NaH 2 PO 4 , 26 mM NaHCO 3 , 10 mM glucose, 2 mM MgCl 2 ) and then transferred to a recording chamber where complete ACSF (containing 2 mM Ca 2+ ) was continuously perfused and bath temperature slowly raised to the experimental setting (34.5 o C). In our experience this procedure maximized the viability of the neurons, in particular C-type cells. Solutions were pre-saturated with carbogen (95% O 2 , 5% CO 2 ) to ensure adequate oxygenation and a pH of 7.4.
Electrophysiology
A glass suction electrode was used to stimulate the spinal nerve and another to record compound action potentials (CAPs) from the DR (Fig. 1A, B ) as described in detail elsewhere (Matsuka and Spigelman 2004) . This served as an indicator of the integrity of sensory axons in individual preparations. Intracellular recordings were conducted using 1.0 mm OD polished-ends borosilicate glass microelectrodes (Model No G100F-4, Warner Instruments, Hamden, CT) pulled to sharpness with the P-87 Flamming/Brown micropipette puller (Sutter Instrument, Novato, CA). Electrodes were filled with 3 M potassium acetate with tip resistances ranging 30-70 MΩ for A-type and 50-120 MΩ for C-type neurons. Electrodes were placed in holders (G23 Instruments, London, UK) connected to the headstage (HS-2) of an amplifier (Axoclamp-2B, Molecular Devices, San Jose, CA). An A/D converter (Digidata 1440A, Molecular Devices) and a computer equipped with pCLAMP 10 software (Molecular Devices) facilitated acquisition (and analysis) of electrophysiological data. Recordings were obtained with the amplifier in Bridge mode with a balanced electrode resistance. The headstage/electrode assembly was advanced with the aid of a Sonnhof Nanostepper (Scientific Precision Instruments GmbH, Oppenheim, Germany). After a neuron was impaled, the spinal nerve was challenged with a range of stimuli of increasing amplitude (0.1-15 mA) and action potential threshold (rheobase) was determined. Cross-depolarization (CD) was recorded in response to subthreshold stimuli, essentially as previously described (Amir and Devor 1996 ): a 10 s train of stimuli 85% of rheobase (up to a maximum of 10 mA amplitude), 0.2 ms duration (0.5 ms for C-cells) and 100 Hz frequency was used, except where otherwise specified.
A-type and C-type cells were classified based on their electrophysiological properties (Amir and Devor 1996) : conduction velocity (CV), the shape of the intracellularly recorded spike (namely the presence (C-type) or absence (A-type) of an inflection on the falling phase) and responses to intracellular hyperpolarizing current injection. CV was calculated by dividing propagation distance (the length of the spinal nerve) by spike latency (time between stimulus and action potential onset) following single suprathreshold stimuli to the spinal nerve. Neurons were discarded if they could not be classified based on the above criteria or if their resting membrane potential (RMP) was less negative than -40 mV (Amir and Devor 1996) .
Determining input resistance
After balancing the amplifier bridge, square wave hyperpolarizing current pulses (1Hz, usually 1-3 nA, 250-500 ms) were delivered intracellularly. Input resistance (R in ) was calculated from the voltage response using Ohm's law. To measure input resistance (R in ) changes during CD, direct intracellular hyperpolarizing current was applied to hyperpolarize the cell to its baseline membrane potential while continuing to deliver the square wave hyperpolarizing current pulses, thus allowing for direct comparison.
Drug treatment
CD amplitude was determined before and after perfusion of the preparation with pharmacological agents dissolved in ACSF at previously demonstrated effective concentrations. Pharmacological agents and concentrations used: 6-Cyano-7- 
Results
In the DRG, synapses are virtually nonexistent and non-synaptic interactions can be observed in a large number of neurons (Amir and Devor 1996) . To study this phenomenon, L5 DRG attached to the spinal nerve (SN) and dorsal root (DR) were excised and kept in near physiological conditions ( Fig. 1A-B ), allowing the SN to be challenged with electrical stimuli while intracellular recordings are obtained from individual neuronal cell bodies in the ganglion (Fig. 1C-F ). SN were stimulated as previously described (Amir and Devor 1996) : stimuli were set at 85% of intensity required to elicit an action potential (rheobase), up to a maximum of 10 mA, ensuring stimuli were sub-threshold for the particular neuron being studied.
Consistent with previous reports, cells typically responded to subthreshold repetitive axonal stimuli with a gradual depolarization, sometimes reaching a plateau, with a gradual repolarization following stimulus cessation (average CD magnitude: A cells=1.9 ± 0.6mV, N=24; C cells=4.2 ± 1.2mV, N=13) ( Fig. 1E-F ). CD response was both stimulus frequency-and intensity-dependent ( Fig. 1E -F) and was associated with an increase in input resistance (average increase during CD in A cells=24.8 ± 8.6%, p=0.009, N=8; C cells=13 ± 5%, p=0.034, N=12, Fig. 2 ), as previously reported (Amir and Devor 1996) .
We next set out to elucidate the mechanism of CD in the DRG, which has been hypothesized to involve a neurochemical agent (Amir and Devor 1996) . In order to identify neurotransmitter(s) involved in CD regulation, we conducted a pharmacological screen. DRG were challenged with commercially available neurotransmitter receptor antagonists and CD recorded before and after drug treatment. In control conditions (perfusion with ACSF, in the absence of pharmacologic agents), magnitude of CD in Atype cells did not change significantly after 8-10 min, the time window used for drug perfusion (p=0.9, N=12, Fig. 3A ). In contrast, unmyelinated C-cells exhibited a significant decline in CD amplitude over time (rundown observed in 44% of cells, average decline=17%, p=0.015, N=9, Fig. 3B ). C-type neurons were generally more challenging to record from, and less stable, than their A-type counterparts, which may explain this occurrence. Therefore, subsequent pharmacology data obtained from C-cells were normalized to factor out this treatment-independent rundown (see Methods section).
Given the fact that virtually all DRG neurons are glutamatergic (Huettner, Kerchner et al. 2002) , we first tested selective blockers of α -amino-3-hydroxy-5-methyl-4isoxazolepropionic acid (AMPA), kainate and N-methyl-D-aspartate (NMDA) glutamate receptors. Combined application of CNQX (10 μM) and AP5 (40 μM) had no statistically significant effect on CD in A-type (p = 0.056, N=20, Fig. 3C ) or C-type (p=0.9, N=10, We next considered the involvement of purinergic receptors. Adenosine triphosphate (ATP) is released from both peripheral and central sensory neuron terminals (Bodin and Burnstock 2001, Sawynok and Liu 2003) , as well as within sensory ganglia (Matsuka, Neubert et al. 2001 , Matsuka, Ono et al. 2008 , and is subsequently hydrolyzed to ADP and further to AMP and adenosine by ectonucleotidases in the DRG (Vongtau, Lavoie et al. 2011 ). We did not focus our analysis on the ionotropic P2X2 and P2X3 receptors because P2X receptors have been shown to mediate membrane potential depolarization associated with increases in membrane conductance (Hiruma and Bourque 1995 , Burgard, Niforatos et al. 1999 , Grubb and Evans 1999 , Xu and Huang 2002 , in contrast to the decrease associated with CD (Amir and Devor 1996) . Moreover, P2X2 and P2X3 receptors are generally subject to relatively rapid desensitization (Brändle, Spielmanns et al. 1997 , Sokolova, Skorinkin et al. 2006 , whereas CD is a non-desensitizing phenomenon up to at least 10 seconds of duration (Amir and Devor 1996) (Fig. 1) . Thus, we next tested the involvement of P2RY1, a purinergic G-protein coupled receptor activated predominantly by adenosine diphosphate (ADP) and which has been associated with increased input resistance and blocking of ion channels (Filippov, Brown et al. 2000 , Filippov, Choi et al. 2006 . P2RY1 is expressed in sensory neurons and has been implicated in thermosensation and nociception (Malin and Molliver 2010 , Molliver, Rau et al. 2011 , Jankowski, Rau et al. 2012 . Treatment with the P2RY1 antagonist, MRS 2179, significantly reduced CD magnitude in A-type cells (p=0.007, N=16, Fig. 4A , E).
A dampened CD response was observed in ~44% of A-type neurons (average reduction=46.5 ± 9%; 50% of cells tested showed no response and 6% showed increased response).
To confirm our observations, we used an additional P2RY1 blocker. MRS 2500 tetraammonium salt is a highly potent, selective and stable antagonist of P2RY1 (Hechler, Nonne et al. 2006 )-it has 100-fold higher binding affinity than MRS 2179 (Hechler, Nonne et al. 2006 ) and superior potency (Jiménez, Clavé et al. 2014) 
IC 50 =8.4nM (Kim, Ohno et al. 2003) , whereas the reported IC 50 for MRS 2179 is one order of magnitude higher, in the 100-300nM range (Kaiser and Buxton 2002) ]. The effect of MRS 2500 treatment was similar to MRS 2179. A significant reduction of CD magnitude was seen in A-type cells (p = 0.012, N=19, Fig. 4C , E), with ~47% of cells showing a dampened CD response (average reduction=41 ± 3%; 42% of cells tested showed no change and 10.5% showed increased response). These data suggest that P2RY1 blockade significantly inhibits CD in a substantial subset of A-type neurons.
We next asked if P2RY1 plays a similar role in unmyelinated, C-type cells. Both P2RY1 pharmacological inhibitors showed a trend toward enhancing CD in a subset of C neurons, with ~46% of cells showing an increased response with either drug (MRS 2179: average increase=150 ± 50%, 27% of cells showed no change and 27% showed decreased CD; MRS 2500: average increase=53 ± 8%, ~46% of cells showed no change and 7% showed decreased CD, Fig. 4B , D, F). This change reached statistical significance for the potent, selective antagonist MRS 2500 (p = 0.018, N=15; MRS 2179: p=0.27, N=11, Fig.   4F ).
Taken collectively, our observations suggest that P2RY1 plays a regulatory role in the DRG, with a cell type-specific effect⎯promoting CD in large myelinated A-type neurons while inhibiting it in unmyelinated C-type cells.
We asked if the effect of P2RY1 blockade on CD magnitude can be explained by changes in input resistance. For this test, we focused on the potent, selective MRS 2500.
We did not find a significant correlation between input resistance change (∆R in ) and CD change (∆CD) with MRS 2500 application (A cells, p=0.098, N=7; C cells, p=0.642, N=8, Pearson correlation). However, given the modest magnitude of the changes in input resistance taking place during CD (~25% for A cells, ~13% for C cells, Fig. 2) , and the fact that drug-induced changes involve a much larger timescale than electrical stimuli (8-10 minutes vs a few seconds), we cannot rule out changes occurring below detection threshold.
We also did not find a consistent association between changes in CD magnitude with P2RY1 blockade (∆CD) and cellular electrical properties. In A-type neurons, CD has also been reported in the nodose ganglion of the vagus, where extracellular calcium plays a central regulatory role⎯eliminating extracellular calcium abrogates the CD response in 60% of neurons (Oh and Weinreich 2002) . We asked if a similar mechanism exists in the DRG. Strikingly, we found no significant decrease of CD magnitude when extracellular calcium was removed, irrespective of cell type (A-type neurons: p=0.744, N=16; C-type neurons: p=0.13, N=10, Fig. 5 ). This observation suggests that CD may involve different cellular mechanisms in different peripheral ganglia.
Glia have been implicated in nonsynaptic neuronal communication (Syková and Chvátal 2000) . In the DRG, satellite glial cells (SGCs) surround neuronal cell bodies and participate in glia/neuron paracrine interactions (Chen, Zhang et al. 2008 , Rozanski, Li et al. 2013 . We asked if glia also play a role in CD. SGC metabolism can be selectively blocked without affecting neuronal function using the gliotoxin fluorocitrate (FC) (Chen, Zhang et al. 2008) . Since the effect of FC is irreversible and requires a lengthy incubation (90 min), rather than analyzing individual cells before and after treatment we focused on changes in average CD magnitude. Average CD magnitude in A-cells was not significantly affected by glial blockade (mean CD=1.9 ± 0.6mV in control conditions; 1.9 ± 0.59mV in the presence of FC; p=0.93; N=24 for control, 26 for FC, Fig. 6A ). However, in C-cells average CD was significantly elevated upon FC-induced glial blockade (mean CD=3.3 ± 1.2mV in control conditions; 10 ± 3mV in the presence of FC; p=0.043; N=10
for control, 8 for FC, Fig. 6A ). FC incubation did not significantly affect the A-cell compound action potential (p=0.7, N=6, Fig. 6B ), suggesting the increased response seen in C-type neurons is not merely a consequence of a larger population of A-type neurons firing. These observations indicate that SGCs play a cell type-specific role in regulating CD in the DRG, inhibiting nonsynaptic crosstalk specifically in unmyelinated C-type neurons.
Discussion
Our findings implicate the purinergic P2RY1 receptor in CD in the rat DRG: P2RY1 blockade inhibited CD in myelinated A-type cells, but enhanced it in C-cells. These results constitute the first report of a neurochemical mechanism for CD in sensory ganglia.
CD is almost universal among DRG neurons (Amir and Devor 1996 )-a region of the nervous system where synapses are exceedingly rare. It also seems prevalent in other sensory ganglia (Oh and Weinreich 2002) , and may thus be a general property of the peripheral nervous system. CD has been shown to be predominantly excitatory, modulating the probability of activation in the affected sensory neurons (Amir and Devor 1996) , although cross-inhibition of mechanoreceptive inputs in DRG of cats after peripheral inflammation has also been demonstrated (Xu and Zhao 2003) . CD has been proposed to be neurotransmitter-mediated, but the specific molecule(s) at stake have remained mysterious. DRG neurons are primarily glutamatergic (Huettner, Kerchner et al. 2002) , and both anatomical and functional studies show widespread ionotropic glutamate receptor expression in the DRG (Shigemoto, Ohishi et al. 1992 , Coggeshall and Carlton 1997 , Lee, Bardoni et al. 2002 , Bardoni, Torsney et al. 2004 , Li, McRoberts et al. 2004 ).
Nonetheless, we found that ionotropic glutamate receptors (AMPA, kainate and NMDA) do not appear to play a major role in CD (Fig. 3) . Simultaneous pharmacological blockade using CNQX/AP5 did not significantly affect CD magnitude, although a modest trend was observed ( Fig. 3) . Thus, although glutamate may play a role in CD in a subset of neurons, it does not appear to substantially regulate CD in most of the DRG. In contrast, the purinergic P2RY1 appears to play a significant effect in substantial subsets of both A-and C-type cells, albeit with cell type-specific effects, namely promoting CD in large myelinated (A-type) and inhibiting it in small, unmyelinated (C-type) neurons.
The role of P2RY1 in CD reported here is consistent with previous reports. CD involves decreased membrane conductance (Amir and Devor 1996) and P2RY1 can trigger excitation of DRG neurons via an inhibition of Kv7 potassium channels (Yousuf, Klinger et al. 2011 , King and Scherer 2012 , Gafar, Rodriguez et al. 2016 ). This downstream mechanism may at least partly explain the regulatory role of P2RY1 in CD.
Our observations are also in keeping with the role of purines in intercellular communication in sensory ganglia (Gerevich, Müller et al. 2005 , Magni and Ceruti 2013 , Magni, Merli et al. 2015 , Rajasekhar, Poole et al. 2015 , Warwick and Hanani 2016 .
Our findings allow us to formulate a first, tentative model of CD in the DRG (Fig.   6C ). Purines released as a result of action potentials (Matsuka, Neubert et al. 2001 , Matsuka, Ono et al. 2008 ) diffuse through the ganglionic stroma and modulate P2RY1 on neighboring cells, with cell-type specific consequences-P2RY1-dependent depolarization of myelinated A-cells and inhibition of CD in C-cells. Our findings also identify an SGC-mediated inhibition of CD in C-type neurons. Whether this accounts for the effect of P2RY1 in C cells or constitutes a separate, additional mechanism is presently unclear. In the DRG, P2RY1 is expressed in both neurons and glia (Chen, Zhang et al. 2008 , Huang, Gu et al. 2013 , Magni and Ceruti 2013 , Rajasekhar, Poole et al. 2015 . Our results indicate that, at least for A-type cells, glial P2RY1 does not play a substantial role in CD, since SGC inactivation does not have a significant impact (Fig.   6A ). Thus in large, myelinated A-cells, P2RY1-mediated crosstalk likely represents a direct, neuron-to-neuron nonsynaptic communication pathway. In C-cells, on the other hand, SGCs do appear to modulate CD. These observations are consistent with structural data indicating that molecules in the DRG extracellular space can more easily access large cells with myelinated axons, whereas SGCs form a tighter, less permeable barrier around small C-type neurons (Shinder and Devor 1994) . Thus, extracellular purines released by activated neurons may diffuse and interact directly with neighboring A-cells (via P2RY1 expressed on their surface), whereas direct access to C-cells may be hindered by the tighter wrapping of SGCs (Shinder and Devor 1994) , with diffusing purines interacting instead with glial P2RY1, and the affected glia in turn regulating CD in the associated small C-type neurons. Alternatively, the effects of glia and P2RY1 identified here may represent separate cellular mechanisms. Additional future work will be required to distinguish between these scenarios. It will also be interesting to probe whether the cell type-specific effect of glia-modulating CD in C-, but not A-cells-explains our observation that P2RY1 antagonists have opposite effects in A-and C-type neurons, blocking CD in the former while potentiating it in the latter. Alternatively, intracellular downstream effectors may execute different action programs in A-and C-neurons, leading to particular cellular responses. Also, more than one ligand may be involved, since P2RY1 is known to bind multiple purines (e.g. ATP and ADP) and to possess at least two discrete extracellular binding sites (Zhang, Gao et al. 2015) .
Myelinated and unmyelinated neurons typically exhibit differences in nonsynaptic communication, but those discrepancies are generally localized to axonal projectionssuch as ephaptic conduction, which tends to occur between unmyelinated, tightly packed fibers (Bokil, Laaris et al. 2001 )-presumably a product of myelin acting as a physical barrier to the release and access of diffusing ligands, such as neurotransmitters or other signaling molecules (Syková and Chvátal 2000 , Sykova 2004 , Sykova 2005 , Damasio and Carvalho 2013 . To our knowledge, this is the first evidence that myelinated and unmyelinated neurons also differ in the nonsynaptic exchanges taking place intraganglionically, away from nerves proper. Exploring further the relationship between glia and nonsynaptic interactions may shed further light on the neurophysiology of sensory signal processing in the peripheral nervous system.
Our findings indicate that CD regulation is multifactorial. Both A-and C-type neurons were found where P2RY1 pharmacologic modulation showed no clear effect.
Moreover, the inhibitory effect of CD by P2RY1 antagonists averaged 41-44%
(depending on the compound used). We employed high concentrations of P2RY1
antagonists. For example, for MRS 2179, the experimental concentration used (100 µM) is 30-100x the reported IC 50 (Anita Jagroop, Burnstock et al. 2003 , Jiménez, Clavé et al. 2014 , and MRS 2179 has been shown to be effective even at 10 µM (Baurand, Raboisson et al. 2001) . Similarly, for MRS 2500, the experimental concentration (1µM) is ~20x the IC 50 (Jiménez, Clavé et al. 2014 ). Yet neither compound induced a 100% abrogation of CD. These findings indicate that additional regulatory mechanisms for CD likely exist. This scenario is consistent with previous reports suggesting a role for extracellular K + , possibly via Nernstian depolarization (Amir and Devor 1996) .
We also found that eliminating extracellular calcium did not significantly affect CD magnitude (Fig. 5) . CD in the DRG may rely on intracellular calcium stores or be entirely calcium-independent. The large-pore membrane channel Pannexin-1 (Panx1) is involved in ATP release and can be opened by cellular depolarization (Locovei, Wang et al. 2006 ) yet operates independently from extracellular calcium (Bruzzone, Barbe et al. 2005) . Panx1 is expressed in DRG neurons, where it plays a role in neuropathic pain (Zhang, Laumet et al. 2015) . CD may involve Panx1-mediated ATP release, which would explain the observed lack of requirement of extracellular calcium. Since extracellular calcium plays a central role in CD in the nodose ganglion of the vagus (Oh and Weinreich 2002) , our findings suggest a fundamental mechanistic difference in CD regulation between these two peripheral sensory ganglia.
The physiological role of CD in sensory ganglia is presently unclear. It has been proposed to represent a feedback mechanism, perhaps modulatory of both neuronal metabolism and excitability (Devor 1999) . The DRG functions as a gateway for action potential propagation (Krames 2014) . Specifically, the somatic/perisomatic compartment-the part of the DRG neuron comprising the cell body, T-junction and the initial axon segment connecting them-is able to modulate the conduction of action potentials from the periphery to the spinal cord, effectively regulating the transmission of sensory information to the CNS (Du, Hao et al. 2014) . As the T-junction is the point of lowest safety for action potential propagation in the peripheral sensory pathway, small changes in membrane voltage can determine the success or failure of impulse conduction, particularly in C-cells. Thus, even modest changes in membrane potential at the somatic/perisomatic compartment-as small as 2-4 mV, i.e. well within the range observed in our experiments-have been shown to interfere with fiber excitability, block action potential propagation and significantly affect pain behaviors (Du, Hao et al. 2014 ).
Thus, CD has the potential to modulate sensory information transmission, nociceptive and otherwise. The remarkable cell-specificity described here-P2RY1 shows contrary effects on A-and C-type neurons-suggests a novel process of neural coding between cognate fibers with a putative role in coordinating sensory information transmission and processing. As such, the potential of CD as a productive target for novel pharmacological approaches to pain control is considerable.
CD can be observed in most neurons in the DRG in normal conditions (Amir and Devor 1996) , and is exacerbated upon injury (Devor and Wall 1990) . CD has also been described in the nodose ganglion of the vagus nerve (Oh and Weinreich 2002) , and may thus represent a general feature of peripheral sensory ganglia. Elucidating the physiological role(s) of CD will likely contribute to our understanding of sensory perception and nociception and may also shed light on the mechanisms of interoceptive processing and affect. The first description of a neurotransmitter mechanism for CD in the DRG constitutes a fundamental first step in that direction. Amplitude of CD response plotted for each individual neuron in the presence ("post") and absence ("pre") of drug treatment. p = 0.056, N = 20. D, AMPAR/KAR/NMDAR blockade does not significantly impact CD magnitude in C-type neurons. Values were normalized to account for the rundown observed in control conditions (see text). p = 0.9, N = 10. C-D, "pre" and "post" drug measurements were 8-10 mins apart. experiences an action potential, triggering ATP release (mediated by channels such as Pannexin 1) into the surrounding extracellular space. Purines (primarily ADP resulting from the extracellular hydrolysis of ATP by ectonucleotidases) bind to P2RY1 on the membrane of neighboring A-cells (red), inducing CD (plus sign). In unmyelinated C-cells (green), on the other hand, the purines/P2RY1 pathway inhibits CD, with SGCs also playing a regulatory role (T-ended arrows and minus signs). Whether purine-induced CD inhibition in C-neurons is mediated by glial and/or neuronal P2RY1 is presently unclear.
Figure Legends
